"FTC Investigates Generic Drug Shortages and Supply Chain Middlemen"
TL;DR Summary
The Federal Trade Commission and the Department of Health and Human Services have launched an inquiry into the causes of generic drug shortages, focusing on the practices of group purchasing organizations and drug distributors. The inquiry aims to assess the influence of these "powerful middlemen" on drug pricing and manufacturing, which has led to critical shortages of drugs such as chemotherapy and antibiotics, endangering patients. Lawmakers and industry executives have expressed concerns about the impact of these practices on the stability of the industry, particularly among makers of sterile injectable products used in surgical and cancer care.
- US Agencies Start Inquiry Into Generic Drug Shortages The New York Times
- Biden administration examining role of supply chain middlemen in generic drug shortages CNBC
- Drug Shortages Trigger FTC Probe - WSJ The Wall Street Journal
- FTC probing drug 'middlemen' over 'critical' generic shortages at hospitals: 'Endangering patients' New York Post
- FTC probes GPOs, drug wholesalers over antitrust concerns Modern Healthcare
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
2 min
vs 3 min read
Condensed
77%
428 → 97 words
Want the full story? Read the original article
Read on The New York Times